Effects of COVID-19 Infection on Symptom Severity and Disability in Multiple Sclerosis
Salter A, Lancia S, Cutter GR, Fox RJ, Marrie RA 2025 Jan Neurology 104 e210149Post-acute sequela of COVID-19 infection in individuals with multiple sclerosis
Salter A, Lancia S, Cutter GR, Fox RJ, Marrie RA 2025 Multiple Sclerosis JournalDoes prism adaptation treatment reduce spatial neglect and improve function?
Chen P, Hreha K, MacPhee C, Salter A, Eskes GA 2025 Frontiers in Rehabilitation Sciences 6Unexpected Low Rate of Amyloid-β Pathology in Multiple Sclerosis Patients
Brier MR, Schindler SE, Salter A, Perantie D, Shelley N, Judge B, Keefe S, Kirmess KM, Verghese PB, Yarasheski KE, Venkatesh V, Raji CA, Gordon BA, Bateman RJ, Morris JC, Naismith RT, Holtzman DM, Benzinger TL, Cross AH 2024 Sep Annals of Neurology 96 453-459Randomised controlled trial of intermittent calorie restriction in people with multiple sclerosis
Ghezzi L, Tosti V, Shi L, Cantoni C, Mikesell R, Lancia S, Zhou Y, Obert K, Dula C, Sen MK, Ge A, Tolentino M, Bollman B, Don AS, Matarese G, Colamatteo A, La Rocca C, Lepore MT, Raji CA, Rahmani F, Wu GF, Naismith RT, Fontana L, Cross AH, Salter A, Piccio L 2024 Aug Journal of Neurology, Neurosurgery and psychiatry 96Access to Care and Health-Related Quality of Life in Multiple Sclerosis
Marrie RA, Lancia S, Cutter GR, Fox RJ, Salter A 2024 Aug Neurology: Clinical Practice 14Focusing on neural mechanisms of exercise training benefits in multiple sclerosis
Sandroff BM, Motl RW, Salter A 2024 Jun Multiple Sclerosis and Related Disorders 86Polygenic liability for anxiety in association with comorbid anxiety in multiple sclerosis
Kowalec K, Harder A, Dolovich C, Fitzgerald KC, Salter A, Lu Y, Bernstein CN, Bolton JM, Cutter G, Fisk JD, Gelernter J, Graff LA, Hägg S, Hitchon CA, Levey DF, Lublin FD, McKay KA, Patten S, Patki A, Stein MB, Tiwari HK, Wolinsky JS, Marrie RA 2024 Jun Annals of Clinical and Translational Neurology 11 1393-1404Increased healthcare utilization in the year before multiple sclerosis diagnosis
Razzak AN, Hernandez RS, Salter A, Obeidat AZ 2024 Mar Multiple Sclerosis and Related Disorders 83Off-Road Testing: Outcome Reporting Bias in Multiple Sclerosis Trials
Marrie RA, Salter A 2024 Feb Neurology 102Investigating the Prevalence of Comorbidity in Multiple Sclerosis Clinical Trial Populations
Salter A, Lancia S, Kowalec K, Fitzgerald KC, Marrie RA 2024 Feb Neurology 102Disease-modifying therapy initiation patterns in multiple sclerosis in three large MS populations
Stahmann A, Craig E, Ellenberger D, Fneish F, Frahm N, Marrie RA, Middleton R, Nicholas R, Rodgers J, Warnke C, Salter A 2024 Jan Therapeutic Advances in Neurological Disorders 17Cladribine tablets after treatment with natalizumab (CLADRINA) – rationale and design
Sguigna PV, Hussain RZ, Okai A, Blackburn KM, Tardo L, Madinawala M, Korich J, Lebson LA, Kaplan J, Salter A, Manouchehri N, Stuve O 2024 Jan Therapeutic Advances in Neurological Disorders 17Increased White Matter Aerobic Glycolysis in Multiple Sclerosis
Brier MR, Judge B, Ying C, Salter A, An H, Patel A, Wang Q, Wang Y, Cross AH, Naismith RT, Benzinger TL, Goyal MS 2024 Annals of Neurology 97 766-778Priority setting: women’s health topics in multiple sclerosis
Ross L, Finlayson M, Amato MP, Cohen JA, Hellwig K, Tintore M, Vukusic S, Salter A, Marrie RA 2024 Frontiers in Neurology 15Improving the efficiency of clinical trials in multiple sclerosis
Marrie RA, Sormani MP, Apap Mangion S, Bovis F, Cheung WY, Cutter GR, Feys P, Hill MD, Koch MW, McCreary M, Mowry EM, Park JJ, Piehl F, Salter A, Chataway J 2023 Aug Multiple Sclerosis Journal 29 1136-1148Severity and worsening of fatigue among individuals with multiple sclerosis
Salter A, Keenan A, Le HH, Gandhi K, Ait-Tihyaty M, Lancia S, Cutter GR, Fox RJ, Marrie RA 2023 Apr Multiple Sclerosis Journal - Experimental, Translational and Clinical 9Attitudes of people with multiple sclerosis toward brain donation
Marrie RA, Kosowan L, Cutter GR, Fox RJ, Salter A 2023 Jan Frontiers in Neurology 14Association of Vitamin D Polygenic Risk Scores and Disease Outcome in People With Multiple Sclerosis
Vasileiou ES, Hu C, Bernstein CN, Lublin F, Wolinsky JS, Cutter GR, Sotirchos ES, Kowalec K, Salter A, Saidha S, Mowry EM, Calabresi PA, Marrie RA, Fitzgerald KC 2023 Jan Neurology: Neuroimmunology and NeuroInflammation 10A Systematic Review of the Validity and Reliability of the Patient-Determined Disease Steps Scale
Marrie RA, McFadyen C, Yaeger L, Salter A 2023 Jan International Journal of MS Care 25 20-25Multiple sclerosis progression: time for a new mechanism-driven framework
Author Collaboration IA, Kuhlmann T, Moccia M, Coetzee T, Cohen JA, Correale J, Graves J, Marrie RA, Montalban X, Yong VW, Thompson AJ, Reich DS, Amato MP, Banwell B, Barkhof F, Chataway J, Chitnis T, Comi G, Derfuss T, Finlayson M, Goldman M, Green A, Hellwig K, Kos D, Miller A, Mowry E, Oh J, Salter A, Sormani MP, Tintore M, Tremlett H, Trojano M, van der Walt A, Vukusic S, Waubant E 2023 Jan The Lancet Neurology 22 78-88Etiology, effects and management of comorbidities in multiple sclerosis: recent advances
Marrie RA, Fisk JD, Fitzgerald K, Kowalec K, Maxwell C, Rotstein D, Salter A, Tremlett H 2023 Frontiers in immunology 14Physical and Mental Health-Related Quality of Life Trajectories Among People With Multiple Sclerosis
O'Mahony J, Salter A, Ciftci-Kavaklioglu B, Fox RJ, Cutter GR, Marrie RA 2022 Oct Neurology 99 E1538-E1548Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β
Simpson-Yap S, Pirmani A, De Brouwer E, Peeters LM, Geys L, Parciak T, Helme A, Hillert J, Moreau Y, Edan G, Spelman T, Sharmin S, McBurney R, Schmidt H, Bergmann A, Braune S, Stahmann A, Middleton R, Salter A, Bebo B, van der Walt A, Butzkueven H, Ozakbas S, Karabudak R, Boz C, Alroughani R, Rojas JI, van der Mei I, Sciascia do Olival G, Magyari M, Alonso R, Nicholas R, Chertcoff A, Zabalza A, Arrambide G, Nag N, Descamps A, Costers L, Dobson R, Miller A, Rodrigues P, Prčkovska V, Comi G, Kalincik T 2022 Oct Multiple Sclerosis and Related Disorders 66COVID-19 in the pregnant or postpartum MS patient: Symptoms and outcomes
Salter A, Cross AH, Cutter GR, Fox RJ, Li DK, Bebo B, Halper J, Kanellis P, Rammohan K, Newsome SD 2022 Sep Multiple Sclerosis and Related Disorders 65Racial disparities in skin tone representation of dermatomyositis rashes: A systematic review
Babool S, Bhai SF, Sanderson C, Salter A, Christopher-Stine L 2022 Jun Rheumatology (United Kingdom) 61 2255-2261Alopecia in Multiple Sclerosis Patients Treated with Disease Modifying Therapies
Porwal MH, Salter A, Patel D, Obeidat AZ 2022 Jun Journal of Central Nervous System Disease 14Quality Control of Magnetic Resonance Elastography Using Percent Measurable Liver Volume Estimation
Ballard DH, Ludwig DR, Fraum TJ, Salter A, Narra VR, Shetty AS 2022 Jun Journal of Magnetic Resonance Imaging 55 1890-1899Attitudes toward coronavirus disease 2019 vaccination in people with multiple sclerosis
Marrie RA, Dolovich C, Cutter GR, Fox RJ, Salter A 2022 Apr Multiple Sclerosis Journal - Experimental, Translational and Clinical 8Alterations of host-gut microbiome interactions in multiple sclerosis
Cantoni C, Lin Q, Dorsett Y, Ghezzi L, Liu Z, Pan Y, Chen K, Han Y, Li Z, Xiao H, Gormley M, Liu Y, Bokoliya S, Panier H, Suther C, Evans E, Deng L, Locca A, Mikesell R, Obert K, Newland P, Wu Y, Salter A, Cross AH, Tarr PI, Lovett-Racke A, Piccio L, Zhou Y 2022 Feb EBioMedicine 76Comparing the MSIS-29 and the Health Utilities Index Mark III in Multiple Sclerosis
Marrie RA, Dolovich C, Cutter GR, Fox RJ, Salter A 2021 Dec Frontiers in Neurology 12Associations of Disease-Modifying Therapies with COVID-19 Severity in Multiple Sclerosis
Simpson-Yap S, De Brouwer E, Kalincik T, Rijke N, Hillert JA, Walton C, Edan G, Moreau Y, Spelman T, Geys L, Parciak T, Gautrais C, Lazovski N, Pirmani A, Ardeshirdavanai A, Forsberg L, Glaser A, McBurney R, Schmidt H, Bergmann AB, Braune S, Stahmann A, Middleton R, Salter A, Fox RJ, Van Der Walt A, Butzkueven H, Alroughani R, Ozakbas S, Rojas JI, Van Der Mei I, Nag N, Ivanov R, Sciascia Do Olival G, Dias AE, Magyari M, Brum D, Mendes MF, Alonso RN, Nicholas RS, Bauer J, Chertcoff AS, Zabalza A, Arrambide G, Fidao A, Comi G, Peeters L 2021 Nov Neurology 97 E1870-E1885NARCOMS and Other Registries in Multiple Sclerosis: Issues and Insights
Marrie RA, Cutter GR, Fox RJ, Vollmer T, Tyry T, Salter A 2021 Nov International Journal of MS Care 23 276-285A Survey of Cannabis Use in a Large US-Based Cohort of People with Multiple Sclerosis
Salter A, Fox RJ, Cutter G, Marrie RA, Nichol KE, Steinerman JR, Smith KM 2021 Nov International Journal of MS Care 23 245-252Comparative responsiveness of the health utilities index and the RAND-12 for multiple sclerosis
Marrie RA, Leung S, Cutter GR, Fox RJ, Salter A 2021 Oct Multiple Sclerosis Journal 27 1781-1789Assessment of Biological Interactions Between Multiple Sclerosis Status and Depression for Mortality
Salter A 2021 Sep Neurology 97 617-618Uptake and Attitudes about Immunizations in People with Multiple Sclerosis
Marrie RA, Kosowan L, Cutter GR, Fox R, Salter A 2021 Aug Neurology: Clinical Practice 11 327-334Results of the 2019 Survey of the American Alliance of Academic Chief Residents in Radiology
Ballard DH, Summers D, Hoegger MJ, Salter A, Gould JE 2021 Jul Academic radiology 28 1018-1028The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis
Author Collaboration ob, Chiaravalloti ND, Amato MP, Brichetto G, Chataway J, Dalgas U, DeLuca J, Meza C, Moore NB, Feys P, Filippi M, Freeman J, Inglese M, Motl R, Rocca MA, Sandroff BM, Salter A, Cutter G, Feinstein A 2021 May Journal of neurology 268 1598-1607Diagnostic performance of LI-RADS version 2018 for evaluation of pediatric hepatocellular carcinoma
Khanna G, Chavhan GB, Schooler GR, Fraum TJ, Alazraki AL, Squires JH, Salter A, Podberesky DJ, Towbin AJ 2021 Apr RADIOLOGY 299 190-199Increased Utilization of Total Joint Arthroplasty after Medicaid Expansion
Dy CJ, Salter A, Barker A, Brown D, Keller M, Olsen MA 2021 Mar Journal of Bone and Joint Surgery 103 524-531Defining phenotypic and functional heterogeneity of glioblastoma stem cells by mass cytometry
Galdieri L, Jash A, Malkova O, Mao DD, DeSouza P, Chu YE, Salter A, Campian JL, Naegle KM, Brennan CW, Wakimoto H, Oh ST, Kim AH, Chheda MG 2021 Feb JCI Insight 6Data harmonization for collaborative research among MS registries: A case study in employment
Salter A, Stahmann A, Ellenberger D, Fneish F, Rodgers WJ, Middleton R, Nicholas R, Marrie RA 2021 Feb Multiple Sclerosis Journal 27 281-289Chemokine Receptor 2–targeted Molecular Imaging in Pulmonary Fibrosis
Brody SL, Gunsten SP, Luehmann HP, Sultan DH, Hoelscher M, Heo GS, Pan J, Koenitzer JR, Lee EC, Huang T, Mpoy C, Guo S, Laforest R, Salter A, Russell TD, Shifren A, Combadiere C, Lavine KJ, Kreisel D, Humphreys BD, Rogers BE, Gierada DS, Byers DE, Gropler RJ, Chen DL, Atkinson JJ, Liu Y 2021 Jan American journal of respiratory and critical care medicine 203 78-89Disease-modifying therapy prescription patterns in people with multiple sclerosis by age
Zhang Y, Salter A, Jin S, Culpepper WJ, Cutter GR, Wallin M, Stuve O 2021 Therapeutic Advances in Neurological Disorders 14T cells producing GM-CSF and IL-13 are enriched in the cerebrospinal fluid of relapsing MS patients
Ghezzi L, Cantoni C, Cignarella F, Bollman B, Cross AH, Salter A, Galimberti D, Cella M, Piccio L 2020 Sep Multiple Sclerosis Journal 26 1172-1186COVID-19 in people with multiple sclerosis: A global data sharing initiative
Peeters LM, Parciak T, Walton C, Geys L, Moreau Y, De Brouwer E, Raimondi D, Pirmani A, Kalincik T, Edan G, Simpson-Yap S, De Raedt L, Dauxais Y, Gautrais C, Rodrigues PR, McKenna L, Lazovski N, Hillert J, Forsberg L, Spelman T, McBurney R, Schmidt H, Bergmann A, Braune S, Stahmann A, Middleton R, Salter A, Bebo BF, Rojas JI, van der Walt A, Butzkueven H, van der Mei I, Ivanov R, Hellwig K, Sciascia do Olival G, Cohen JA, Van Hecke W, Dobson R, Magyari M, Brum DG, Alonso R, Nicholas R, Bauer J, Chertcoff A, de Sèze J, Louapre C, Comi G, Rijke N 2020 Sep Multiple Sclerosis Journal 26 1157-1162Comorbidity is associated with disease activity in MS: Findings from the CombiRx trial
Salter A, Kowalec K, Fitzgerald KC, Cutter G, Marrie RA 2020 Aug Neurology 95 E446-E456Developing a crosswalk between the RAND-12 and the health utilities index for multiple sclerosis
Marrie RA, Dufault B, Tyry T, Cutter GR, Fox RJ, Salter A 2020 Aug Multiple Sclerosis Journal 26 1102-1110A Color Flow Tract in Ultrasound-Guided Random Renal Core Biopsy Predicts Complications
Gagnon MH, Lin MF, Lancia S, Salter A, Yano M 2020 Jul Journal of Ultrasound in Medicine 39 1335-1342Clinical instrument to retrospectively capture levels of EDSS
Ciotti JR, Sanders N, Salter A, Berger JR, Cross AH, Chahin S 2020 Apr Multiple Sclerosis and Related Disorders 39Outcome of Lesser Metatarsophalangeal Joint Interpositional Arthroplasty With Tendon Allograft
Stautberg EF, Klein SE, McCormick JJ, Salter A, Johnson JE 2020 Mar Foot and Ankle International 41 313-319Dual antiplatelets in IV thrombolysis: How much is too much?
Lioutas VA, Salter A 2020 Feb Neurology 94 289-290Infectious disease consultation for candidaemia – Authors' reply
Mejia-Chew C, O'Halloran JA, Olsen MA, Stwalley D, Salter A, Powderly WG, Spec A 2020 Feb The Lancet Infectious Diseases 20 165-166Heterogeneity Diffusion Imaging of gliomas: Initial experience and validation
Wang Q, Guzmán Pérez-Carrillo GJ, Ponisio MR, LaMontagne P, Dahiya S, Marcus DS, Milchenko M, Shimony J, Liu J, Chen G, Salter A, Massoumzadeh P, Miller-Thomas MM, Rich KM, McConathy J, Benzinger TL, Wang Y 2019 Nov PloS one 14Prospective natural history study of C9orf72 ALS clinical characteristics and biomarkers
Cammack AJ, Atassi N, Hyman T, Van Den Berg LH, Harms M, Baloh RH, Brown RH, Van Es MA, Veldink JH, De Vries BS, Rothstein JD, Drain C, Jockel-Balsarotti J, Malcolm A, Boodram S, Salter A, Wightman N, Yu H, Sherman AV, Esparza TJ, McKenna-Yasek D, Owegi MA, Douthwright C, McCampbell A, Ferguson T, Cruchaga C, Cudkowicz M, Miller TM 2019 Oct Neurology 93 E1605-E1617Functional gastrointestinal disorders negatively affect health-related quality of life in MS
Marrie RA, Leung S, Tyry T, Cutter GR, Fox R, Salter A 2019 Oct Neurology: Clinical Practice 9 381-390Measurement repeatability of 18F-FDG PET/CT versus 18F-FDG PET/MRI in solid tumors of the pelvis
Fraum TJ, Fowler KJ, Crandall JP, Laforest RA, Salter A, An H, Jacobs MA, Grigsby PW, Dehdashti F, Wahl RL 2019 Aug Journal of Nuclear Medicine 60 1080-1086CT IVC venogram: normalized quantitative criteria for patency and thrombosis
Mityul M, Kim DJ, Salter A, Yano M 2019 Jun Abdominal Radiology 44 2262-2267Clinical trials in multiple sclerosis: potential future trial designs
Manouchehri N, Zhang Y, Salter A, Hussain RZ, Hartung HP, Hemmer B, Linker R, Segal BM, Cutter G, Stüve O 2019 May Therapeutic Advances in Neurological Disorders 1268Ga-Galmydar: A PET imaging tracer for noninvasive detection of Doxorubicin-induced cardiotoxicity
Sivapackiam J, Kabra S, Speidel S, Sharma M, Laforest R, Salter A, Rettig MP, Sharma V 2019 May PloS one 14Validation of the SymptoMScreen with performance-based or clinician-assessed outcomes
Fitzgerald KC, Salter A, Tyry T, Fox RJ, Cutter G, Mowry EM, Marrie RA 2019 Apr Multiple Sclerosis and Related Disorders 29 86-93Use of eHealth and mHealth technology by persons with multiple sclerosis
Marrie RA, Leung S, Tyry T, Cutter GR, Fox R, Salter A 2019 Jan Multiple Sclerosis and Related Disorders 27 13-19Image processing to improve detection of mesial temporal sclerosis in adults
Dahi F, Parsons MS, Orlowski HL, Salter A, Dahiya S, Sharma A 2019 American Journal of Neuroradiology 40 798-801Evaluating the utility of a postprocessing algorithm for MRI evaluation of optic neuritis
Stunkel L, Sharma A, Parsons MS, Salter A, Van Stavern GP 2019 American Journal of Neuroradiology 40 1043-1048Pseudobulbar affect prevalence and association with symptoms inmultiple sclerosis
Fitzgerald KC, Salter A, Tyry T, Fox RJ, Cutter G, Marrie RA 2018 Dec Neurology: Clinical Practice 8 472-481Hepatopancreaticobiliary imaging second-opinion consultations: Is there value in the second reading?
Shetty AS, Mittal A, Salter A, Narra VR, Fowler KJ 2018 Dec American Journal of Roentgenology 211 1264-1272Evaluation of noncontrast MR enterography for pediatric inflammatory bowel disease assessment
Lanier MH, Shetty AS, Salter A, Khanna G 2018 Aug Journal of Magnetic Resonance Imaging 48 341-348Intermittent Fasting Confers Protection in CNS Autoimmunity by Altering the Gut Microbiota
Cignarella F, Cantoni C, Ghezzi L, Salter A, Dorsett Y, Chen L, Phillips D, Weinstock GM, Fontana L, Cross AH, Zhou Y, Piccio L 2018 Jun Cell Metabolism 27 1222-1235.e6Risk factors and prognostic significance of altered left ventricular geometry in preterm infants
Choudhry S, Salter A, Cunningham TW, Levy PT, Hackett BP, Singh GK, Johnson MC 2018 May Journal of Perinatology 38 543-549A survey of dietary characteristics in a large population of people with multiple sclerosis
Fitzgerald KC, Tyry T, Salter A, Cofield SS, Cutter G, Fox RJ, Marrie RA 2018 May Multiple Sclerosis and Related Disorders 22 12-18Quantitative multiparametric mr analysis of small renal lesions: Correlation with surgical pathology
Yano M, Fowler KJ, Srisuwan S, Salter A, Siegel CL 2018 Apr Abdominal Radiology 43 3390-3399Denali, Tulip, and Option Inferior Vena Cava Filter Retrieval: A Single Center Experience
Ramaswamy RS, Jun E, van Beek D, Mani N, Salter A, Kim SK, Akinwande O 2018 Apr Cardiovascular and Interventional Radiology 41 572-577Factors associated with excessive sitting time in multiple sclerosis
Sasaki JE, Motl RW, Cutter G, Marrie RA, Tyry T, Salter A 2018 Apr Multiple Sclerosis and Related Disorders 21 71-77Analysis of weight changes after left gastric artery embolization in a cancer-naive population
Kim DJ, Raman HS, Salter A, Ramaswamy R, Gunn AJ, Weiss CR, Akinwande O 2018 Mar Diagnostic and Interventional Radiology 24 94-97Treatment satisfaction and bothersome bladder, bowel, sexual symptoms in multiple sclerosis
Wang G, Marrie RA, Fox RJ, Tyry T, Cofield SS, Cutter GR, Salter A 2018 Feb Multiple Sclerosis and Related Disorders 20 16-21National estimates of self-reported sitting time in adults with multiple sclerosis
Sasaki JE, Motl RW, Cutter G, Marrie RA, Tyry T, Salter A 2018 Jan Multiple Sclerosis Journal - Experimental, Translational and Clinical 4Diet quality is associated with disability and symptom severity in multiple sclerosis
Fitzgerald KC, Tyry T, Salter A, Cofield SS, Cutter G, Fox R, Marrie RA 2018 Jan Neurology 90 E1-E11Limbic system damage in MS: MRI assessment and correlations with clinical testing
Wen J, Yablonskiy DA, Salter A, Cross AH 2017 Nov PloS one 12The link between smoking status and co-morbid conditions in individuals with multiple sclerosis (MS)
Newland P, Flick L, Salter A, Dixon D, Jensen MP 2017 Oct Disability and Health Journal 10 587-591Author response: High hypothetical interest in physician-assisted death in multiple sclerosis
Marrie RA, Salter A, Tyry T, Cutter GR, Fox RJ 2017 Sep Neurology 89 1429-1430Perspectives on marijuana use and effectiveness: A survey of NARCOMS participants
Cofield SS, Salter A, Tyry T, Crowe C, Cutter GR, Fox RJ, Marrie RA 2017 Aug Neurology: Clinical Practice 7 333-343Normative Left Ventricular M-Mode Echocardiographic Values in Preterm Infants up to 2 kg
Choudhry S, Salter A, Cunningham TW, Levy PT, Nguyen HH, Wallendorf M, Singh GK, Johnson MC 2017 Aug Journal of the American Society of Echocardiography 30 781-789.e4Identity Concealment and Chronic Illness: A Strategic Choice
Cook JE, Salter A, Stadler G 2017 Jun Journal of Social Issues 73 359-378Employment and absenteeism in working-age persons with multiple sclerosis
Salter A, Thomas N, Tyry T, Cutter G, Marrie RA 2017 May Journal of Medical Economics 20 493-502High hypothetical interest in physician-assisted death in multiple sclerosis
Marrie RA, Salter A, Tyry T, Cutter GR, Cofield S, Fox RJ 2017 Apr Neurology 88 1528-1534Trigeminal neuralgia commonly precedes the diagnosis of multiple sclerosis
Fallata A, Salter A, Tyry T, Cutter GR, Marrie RA 2017 International Journal of MS Care 19 240-246Examining the joint effect of disability, health behaviors, and comorbidity on mortality in MS
Salter A, Tyry T, Wang G, Fox RJ, Cutter G, Marrie RA 2016 Oct Neurology: Clinical Practice 6 397-408Health insurance affects the use of disease-modifying therapy in multiple sclerosis
Wang G, Marrie RA, Salter AR, Fox R, Cofield SS, Tyry T, Cutter GR 2016 Jul Neurology 87 365-374Two-group time-to-event continual reassessment method using likelihood estimation
Salter A, O'Quigley J, Cutter GR, Aban IB 2015 Nov Contemporary Clinical Trials 45 340-345Implementation of a two-group likelihood time-to-event continual reassessment method using SAS
Salter A, Morgan C, Aban IB 2015 Oct Computer Methods and Programs in Biomedicine 121 189-196Risk tolerance to MS therapies: Survey results from the NARCOMS registry
Fox RJ, Salter A, Alster JM, Dawson NV, Kattan MW, Miller D, Ramesh S, Tyry T, Wells BW, Cutter G 2015 May Multiple Sclerosis and Related Disorders 4 241-249Impact of multiple sclerosis relapse: The NARCOMS participant perspective
Nickerson M, Cofield SS, Tyry T, Salter AR, Cutter GR, Marrie RA 2015 May Multiple Sclerosis and Related Disorders 4 234-240Prevalence of multiple sclerosis symptoms across lifespan: data from the NARCOMS Registry
Fox RJ, Bacon TE, Chamot E, Salter AR, Cutter GR, Kalina JT, Kister I 2015 Neurodegenerative disease management 5 3-10Patient perspectives on switching disease-modifying therapies in the NARCOMS registry
Salter AR, Marrie RA, Agashivala N, Belletti DA, Kim E, Cutter GR, Cofield SS, Tyry T 2014 Jul Patient Preference and Adherence 8 971-979Improvement of multiple sclerosis-associated tremor as a treatment effect of natalizumab
Rinker JR, Salter AR, Cutter GR 2014 Jul Multiple Sclerosis and Related Disorders 3 505-512"Seeing" in NARCOMS: A look at vision-related quality of life in the NARCOMS registry
Salter AR, Tyry T, Vollmer T, Cutter GR, Marrie RA 2013 Jun Multiple Sclerosis Journal 19 953-960Disability in multiple sclerosis: A reference for patients and clinicians
Kister I, Chamot E, Salter AR, Cutter GR, Bacon TE, Herbert J 2013 Mar Neurology 80 1018-1024Randomized study combining interferon and glatiramer acetate in multiple sclerosis
Lublin FD, Cofield SS, Cutter GR, Conwit R, Narayana PA, Nelson F, Salter AR, Gustafson T, Wolinsky JS 2013 Mar Annals of Neurology 73 327-340Measures of neurological impairment and disability in multiple sclerosis
Cutter GR, Morgan CJ, Salter AR, Coield SS, Balcer LJ 2011 Dec 56-64Factors that influence adherence with disease-modifying therapy in MS
Treadaway K, Cutter G, Salter A, Lynch S, Simsarian J, Corboy J, Jeffery D, Cohen B, Mankowski K, Guarnaccia J, Schaeffer L, Kanter R, Brandes D, Kaufman C, Duncan D, Marder EJ, Allen A, Harney J, Cooper J, Woo D, Stuve O, Racke M, Frohman E 2009 Apr Journal of neurology 256 568-576Retinal architecture predicts pupillary reflex metrics in MS
Salter AR, Conger A, Frohman TC, Zivadinov R, Eggenberger E, Calabresi P, Cutter G, Balcer L, Frohman E 2009 Multiple Sclerosis 15 479-486Reproducibility of optical coherence tomography in multiple sclerosis
Cettomai D, Pulicken M, Gordon-Lipkin E, Salter A, Frohman TC, Conger A, Zhang X, Cutter G, Balcer LJ, Frohman E, Calabresi PA 2008 Sep Archives of neurology 65 1218-1222Break in binocular fusion during head turning in MS patients with INO
Mills DA, Frohman TC, Davis SL, Salter AR, McClure S, Beatty I, Shah A, Galetta S, Eggenberger E, Zee DS, Frohman E 2008 Aug Neurology 71 458-460Accuracy of clinical detection of INO in MS: Corroboration with quantitative infrared oculography
Frohman TC, Frohman E, O'Suilleabhain PE, Salter A, Dewey RB, Hogan RN, Galetta S, Lee AG, Straumann D, Noseworthy J, Zee D, Corbett J, Corboy J, Rivera VM, Kramer PD 2003 Sep Neurology 61 848-850